Laurus Labs Ltd
Laurus Labs Ltd (LAURUSLABS) last traded at ₹1,865, a market capitalisation of ₹1,00,768 crore, on a P/E of 92.2. Over the past 52 weeks the stock has ranged between ₹823 and ₹1,871. Laurus Labs Ltd last reported results for the quarter ended Jun 2026, with sales of ₹2,026 crore and net profit of ₹362 crore. Figures are as of 25 Aug 2026 and are not real time.
Laurus Labs Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Laurus Labs Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹2,026 cr, up 29.0% from ₹1,570 cr a year earlier. Net profit was ₹362 cr, up 123.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,224 | 1,415 | 1,720 | 1,570 | 1,653 | 1,778 | 1,812 | 2,026 |
| Expenses | 1,045 | 1,130 | 1,300 | 1,187 | 1,250 | 1,298 | 1,299 | 1,388 |
| Operating profit | 178 | 285 | 421 | 382 | 403 | 480 | 512 | 638 |
| OPM % | 15% | 20% | 24% | 24% | 24% | 27% | 28% | 32% |
| Other income | 5 | 9 | 59 | 10 | 27 | 6 | 12 | 9 |
| Interest | 53 | 58 | 56 | 52 | 40 | 39 | 40 | 42 |
| Depreciation | 108 | 106 | 110 | 117 | 120 | 121 | 122 | 124 |
| Profit before tax | 23 | 131 | 312 | 224 | 270 | 327 | 361 | 481 |
| Tax % | 22% | 31% | 25% | 28% | 28% | 22% | 22% | 25% |
| Net profit | 20 | 93 | 233 | 162 | 194 | 252 | 282 | 362 |
| EPS (₹) | 0.37 | 1.71 | 4.33 | 3.02 | 3.61 | 4.66 | 5.17 | 6.80 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Laurus Labs Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 4,814 | 4,936 | 6,041 | 5,041 | 5,554 | 6,813 | 7,270 |
| Operating profit | 1,552 | 1,424 | 1,592 | 779 | 1,055 | 1,785 | 2,034 |
| OPM % | 32% | 29% | 26% | 15% | 19% | 26% | 28% |
| Net profit | 984 | 832 | 793 | 162 | 358 | 890 | 1,091 |
| EPS (₹) | 18.33 | 15.40 | 14.67 | 2.98 | 6.64 | 16.46 | 20.24 |
TTM is the trailing twelve months to the most recent quarter.
Laurus Labs Ltd growth and returns
- 10 Years
- 14%
- 5 Years
- 7%
- 3 Years
- 4%
- TTM
- 23%
- 10 Years
- 21%
- 5 Years
- -2%
- 3 Years
- 4%
- TTM
- 115%
- 10 Years
- %
- 5 Years
- 22%
- 3 Years
- 67%
- 1 Year
- 106%
- 10 Years
- 17%
- 5 Years
- 15%
- 3 Years
- 10%
- Last Year
- 18%
Laurus Labs Ltd shareholding pattern
Promoters held 27.47% at Jun 2026, broadly unchanged since Jun 2025. FIIs 28.00% and DIIs 13.73%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 27.18% | 27.62% | 27.62% | 27.60% | 27.60% | 27.49% | 27.49% | 27.47% |
| FIIs | 26.08% | 25.56% | 25.51% | 25.70% | 26.17% | 26.52% | 25.82% | 28.00% |
| DIIs | 13.05% | 12.74% | 11.78% | 11.94% | 11.72% | 12.42% | 13.96% | 13.73% |
| Public | 33.69% | 34.09% | 35.09% | 34.78% | 34.52% | 33.57% | 32.73% | 30.79% |
| No. of shareholders | 3,09,063 | 2,92,214 | 2,92,905 | 2,80,223 | 2,83,678 | 2,80,756 | 2,92,281 | 2,91,653 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Laurus Labs Ltd corporate filings
- Please see annexed enclosure.Company Updatelow impact
Cruxal's analysis: Laurus Labs has filed a routine intimation regarding an upcoming analyst or investor…
Read the full analysis - Please see annexed enclosure.Company Updatelow impact
Cruxal's analysis: Laurus Labs has submitted an intimation regarding the receipt of an ESG score from NSE…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Laurus Labs Ltd
Cruxal reads every Laurus Labs Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.